Clinical Training Course: Urology

Prostate Cancer: Questions and Answers

Drs. Phillip L. Ross, Peter Carroll, Mack Roach, II, and Charles J. Ryan

Discuss critical issues surrounding the use of chemoprevention; Review current avenues for administering chemopreventive therapy; Evaluate the potential risks and benefits associated with active surveillance; Determined when and how long patients should receive a combination of radiation and hormone therapy; and Trace the evolution of the current definition of high-risk prostate cancer.

New Frontiers in Prostate Cancer Management

Drs. E. David Crawford and David C. Beyer

Discuss the role of targeted therapy in the management of hormone refractory prostate cancer; Describe concepts underlying active cellular immunotherapy with sipuleucel-T and targeted small molecule therapy using atrasentan; Explore correlations in demographic and clinical data between prostate cancer and breast cancer; Assess the clinical merits of early hormonal therapy in the management of prostate cancer; and Determined the present and future role or robotic surgery in prostate cancer management.